Sciencast Management’s West Pharmaceutical WST Stock Holding History

Sciencast Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$445K	Buy	+1,201	New	+$424K	0.18%	154
2026 Q1	–	Sell	-4,421	Closed	-$1.22M	–	414
2025 Q4	$1.22M	Buy	+4,421	New	+$1.21M	0.17%	177
2024 Q3	–	Sell	-1,390	Closed	-$458K	–	365
2024 Q2	$458K	Buy	+1,390	New	+$491K	0.16%	178
2021 Q4	–	Sell	-1,500	Closed	-$610K	–	637
2021 Q3	$610K	Buy	+1,500	New	+$632K	0.17%	179
2021 Q2	–	Sell	-1,358	Closed	-$397K	–	728
2021 Q1	$397K	Buy	+1,358	New	+$389K	0.08%	330
2020 Q4	–	Sell	-1,001	Closed	-$301K	–	632
2020 Q3	$301K	Buy	+1,001	New	+$265K	0.11%	283
2020 Q2	–	Sell	-1,538	Closed	-$239K	–	536
2020 Q1	$239K	Sell	1,538 -3,112	-67%	-$479K	0.07%	213
2019 Q4	$701K	Buy	4,650 +1,301	+39%	+$189K	0.19%	185
2019 Q3	$480K	Buy	+3,349	New	+$461K	0.16%	214
2017 Q3	–	Sell	-5,992	Closed	-$566K	–	491
2017 Q2	$566K	Buy	5,992 +2,945	+97%	+$271K	0.31%	117
2017 Q1	$249K	Buy	+3,047	New	+$255K	0.14%	242
2016 Q1	–	Sell	-3,994	Closed	-$241K	–	286
2015 Q4	$241K	Buy	+3,994	New	+$240K	0.25%	145

Other funds holding WST

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Sciencast Management's WST Position: Q3 2026 in Review

Sciencast Management opened a new position in West Pharmaceutical (WST) in Q3 2026: 1,201 shares worth $445K. The stake represents 0.18% of the portfolio and ranks #154 among its holdings. This is a return to the name: Sciencast Management previously reported a position in WST as recently as Q4 2025.

Sciencast Management first reported a position in WST in Q4 2015 and has held it in 12 quarters since. The position peaked at $1.22M in Q4 2025. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Sciencast Management held 1,201 shares of West Pharmaceutical worth $445K as of Q3 2026.
West Pharmaceutical was a new Sciencast Management position in Q3 2026.
West Pharmaceutical made up 0.18% of Sciencast Management's portfolio in Q3 2026, its #154 holding.
Sciencast Management first reported a position in West Pharmaceutical in Q4 2015 and has held it in 12 quarters since.
Sciencast Management's West Pharmaceutical position peaked at $1.22M in Q4 2025.
716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Sciencast Management's 13F filing for Q3 2026, filed 13 Nov 2026.